Novel treatment modalities for pelvic inflammatory disease using immunomodulating therapy

<p> <b>Yu.E. Dobrokhotova, P.A. Shadrova</b> </p> <p> <b>Pirogov Russian National Research Medical University, Moscow, Russian Federation</b> </p> <p> <i>Pelvic inflammatory disease (PID) is a significant issue of public health due to its d...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu.E. Dobrokhotova (Author), P.A. Shadrova (Author)
Format: Book
Published: LCC «Medicine-Inform», 2021-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_dbe89ed87d6a40d7af932cfef03c19e1
042 |a dc 
100 1 0 |a Yu.E. Dobrokhotova  |e author 
700 1 0 |a P.A. Shadrova  |e author 
245 0 0 |a Novel treatment modalities for pelvic inflammatory disease using immunomodulating therapy 
260 |b LCC «Medicine-Inform»,   |c 2021-05-01T00:00:00Z. 
500 |a 2618-8430 
500 |a 2686-7184 
520 |a <p> <b>Yu.E. Dobrokhotova, P.A. Shadrova</b> </p> <p> <b>Pirogov Russian National Research Medical University, Moscow, Russian Federation</b> </p> <p> <i>Pelvic inflammatory disease (PID) is a significant issue of public health due to its devastating effects on female reproductive health and fertility. Despite extensive development of medicine and the emergence of novel groups of antibacterial agents, the risks of antibacterial resistance rapidly grow, thus requiring complex treatment of infectious inflammatory disorders caused by bacterial flora. The modulation of immune response is the heart of recently developed treatment modalities for various diseases (infections, oncology etc.). A detailed understanding of molecular immunology contributes to the rational development of novel types of immunotherapy, which can be successfully introduced into clinical practice. Numerous findings demonstrate the efficacy of inosine pranobex for various diseases, in particular, in immunocompromised patients. This medication has proven itself due to good tolerability and the lack of serious side effects. Inosine pranobex being a  safe drug that can be used in many treatment schedules, including complex treatment for chronic PID with antibacterial agents.</i> </p> <p> <i><b>Keywords:</b> inosine pranobex, pelvic inflammatory disease, salpingo-oophoritis, infertility, immunotherapy, sexually transmitted infections, bacterial vaginosis.</i> </p> <p> <i><b>For citation:</b> Dobrokhotova Yu.E., Shadrova P.A. Novel treatment modalities for pelvic inflammatory disease using immunomodulating therapy. Russian Journal of Woman and Child Health. 2021;4(2):149-154. DOI: 10.32364/2618-8430-2021-4-2-149-154.</i> </p> <i><br> </i><br> 
546 |a RU 
690 |a Pediatrics 
690 |a RJ1-570 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n РМЖ. Мать и дитя, Vol 4, Iss 2 (2021) 
787 0 |n http://wchjournal.com/upload/iblock/b13/b13f5411530e84d856ca6c9d9c326e16.pdf 
787 0 |n https://doaj.org/toc/2618-8430 
787 0 |n https://doaj.org/toc/2686-7184 
856 4 1 |u https://doaj.org/article/dbe89ed87d6a40d7af932cfef03c19e1  |z Connect to this object online.